Advertisement
Screener

CRYOPORT, INC. (CYRX) Weighted Average Number of Shares Outstanding, Basic and Diluted

2.8 / 5 stars · 68/120 Roast Me

CRYOPORT, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted

CRYOPORT, INC. (CYRX) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 46.14 million shares for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.

Discontinued › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-11-04

  • CRYOPORT, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 46.14M shares, a 17.86% increase year-over-year.
  • CRYOPORT, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 45.76M shares, a 19.53% increase year-over-year.
  • CRYOPORT, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 43.80M shares, a 16.66% increase year-over-year.
  • CRYOPORT, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 39.70M shares, a 9.57% increase year-over-year.
  • CRYOPORT, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 38.58M shares, a 15.54% increase from fiscal 2019.
  • CRYOPORT, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 33.39M shares, a 18.37% increase from fiscal 2018.
  • CRYOPORT, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 28.21M shares, a 22.85% increase from fiscal 2017.
  • CRYOPORT, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 22.96M shares, a 61.48% increase from fiscal 2016.
Period endWeighted Average Number of Shares Outstanding, Basic and Diluted 3 monthWeighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filedWeighted Average Number of Shares Outstanding, Basic and Diluted 6 monthWeighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filedWeighted Average Number of Shares Outstanding, Basic and Diluted 9 monthWeighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filedWeighted Average Number of Shares Outstanding, Basic and Diluted 12 monthWeighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed
2021-09-3046.14M shares
10-Q · filed 2021-11-04
45.95M shares
derived: average of 2 quarters · filed 2021-11-04
45.22M shares
10-Q · filed 2021-11-04
43.85M shares
derived: average of 4 quarters · filed 2021-11-04
2021-06-3045.76M shares
10-Q · filed 2021-08-06
44.79M shares
10-Q · filed 2021-08-06
43.09M shares
derived: average of 3 quarters · filed 2021-08-06
42.10M shares
derived: average of 4 quarters · filed 2021-11-04
2021-03-3143.80M shares
10-Q · filed 2021-05-06
41.75M shares
derived: average of 2 quarters · filed 2021-05-06
40.88M shares
derived: average of 3 quarters · filed 2021-11-04
40.23M shares
derived: average of 4 quarters · filed 2021-11-04
2020-12-3139.70M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
39.42M shares
derived: average of 2 quarters · filed 2021-11-04
39.04M shares
derived: average of 3 quarters · filed 2021-11-04
38.58M shares
10-K · filed 2021-03-01
2020-09-3039.14M shares
10-Q · filed 2021-11-04
38.71M shares
derived: average of 2 quarters · filed 2021-11-04
38.21M shares
10-Q · filed 2021-11-04
37.80M shares
derived: average of 4 quarters · filed 2021-11-04
2020-06-3038.28M shares
10-Q · filed 2021-08-06
37.91M shares
10-Q · filed 2021-08-06
37.35M shares
derived: average of 3 quarters · filed 2021-08-06
36.93M shares
derived: average of 4 quarters · filed 2021-08-06
2020-03-3137.55M shares
10-Q · filed 2021-05-06
36.89M shares
derived: average of 2 quarters · filed 2021-05-06
36.48M shares
derived: average of 3 quarters · filed 2021-05-06
35.16M shares
derived: average of 4 quarters · filed 2021-05-06
2019-12-3136.23M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
35.95M shares
derived: average of 2 quarters · filed 2021-03-01
34.36M shares
derived: average of 3 quarters · filed 2021-03-01
33.39M shares
10-K · filed 2021-03-01
2019-09-3035.67M shares
10-Q · filed 2020-11-06
33.43M shares
derived: average of 2 quarters · filed 2020-11-06
32.45M shares
10-Q · filed 2020-11-06
31.69M shares
derived: average of 4 quarters · filed 2020-11-06
2019-06-3031.18M shares
10-Q · filed 2020-08-10
30.81M shares
10-Q · filed 2020-08-10
30.36M shares
derived: average of 3 quarters · filed 2020-08-10
29.96M shares
derived: average of 4 quarters · filed 2020-08-10
2019-03-3130.44M shares
10-Q · filed 2020-05-08
29.95M shares
derived: average of 2 quarters · filed 2020-05-08
29.56M shares
derived: average of 3 quarters · filed 2020-05-08
29.12M shares
derived: average of 4 quarters · filed 2020-05-08
2018-12-3129.47M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10
29.12M shares
derived: average of 2 quarters · filed 2020-03-10
28.68M shares
derived: average of 3 quarters · filed 2020-03-10
28.21M shares
10-K · filed 2020-03-10
2018-09-3028.77M shares
10-Q · filed 2019-11-12
28.29M shares
derived: average of 2 quarters · filed 2019-11-12
27.79M shares
10-Q · filed 2019-11-12
27.23M shares
derived: average of 4 quarters · filed 2019-11-12
2018-06-3027.81M shares
10-Q · filed 2019-08-09
27.29M shares
10-Q · filed 2019-08-09
26.72M shares
derived: average of 3 quarters · filed 2019-08-09
26.20M shares
derived: average of 4 quarters · filed 2019-08-09
2018-03-3126.77M shares
10-Q · filed 2019-05-09
26.17M shares
derived: average of 2 quarters · filed 2019-05-09
25.66M shares
derived: average of 3 quarters · filed 2019-05-09
25.24M shares
derived: average of 4 quarters · filed 2019-05-09
2017-12-3125.57M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13
25.10M shares
derived: average of 2 quarters · filed 2019-03-13
24.72M shares
derived: average of 3 quarters · filed 2019-03-13
22.96M shares
10-K · filed 2019-03-13
2017-09-3024.63M shares
10-Q · filed 2018-11-08
24.30M shares
derived: average of 2 quarters · filed 2018-11-08
22.09M shares
10-Q · filed 2018-11-08
20.76M shares
derived: average of 4 quarters · filed 2018-11-08
2017-06-3023.97M shares
10-Q · filed 2018-08-09
20.80M shares
10-Q · filed 2018-08-09
19.48M shares
derived: average of 3 quarters · filed 2018-08-09
18.39M shares
derived: average of 4 quarters · filed 2018-08-09
2017-03-3117.60M shares
10-Q · filed 2018-05-03
17.23M shares
derived: average of 2 quarters · filed 2018-05-03
16.53M shares
derived: average of 3 quarters · filed 2018-05-03
15.94M shares
derived: average of 4 quarters · filed 2018-05-03
2016-12-3116.85M shares
derived: 10-K 9 month − 10-Q 6 month · filed 2018-03-08
15.99M shares
derived: average of 2 quarters · filed 2018-03-08
15.39M shares
10-K · filed 2018-03-08
14.22M shares
10-K · filed 2018-03-08
2016-09-3015.12M shares
10-Q · filed 2017-11-02
14.66M shares
10-Q · filed 2016-11-14
13.34M shares
10-Q · filed 2017-11-02
11.79M shares
derived: average of 4 quarters · filed 2017-11-02
2016-06-3014.20M shares
10-Q · filed 2017-08-09
12.43M shares
10-Q · filed 2017-08-09
10.68M shares
derived: average of 3 quarters · filed 2017-08-09
9.63M shares
derived: average of 4 quarters · filed 2017-08-09
2016-03-3110.60M shares
10-Q · filed 2017-05-04
8.91M shares
derived: average of 2 quarters · filed 2017-05-04
8.11M shares
derived: average of 3 quarters · filed 2017-05-04
7.34M shares
10-KT · filed 2017-03-13
2015-12-317.23M shares
10-Q · filed 2016-02-11
6.87M shares
derived: average of 2 quarters · filed 2016-11-14
6.26M shares
10-KT · filed 2017-03-13
5.95M shares
derived: average of 4 quarters · filed 2016-11-14
2015-09-306.51M shares
10-Q · filed 2016-11-14
5.77M shares
10-Q · filed 2016-11-14
5.53M shares
derived: average of 3 quarters · filed 2016-11-14
5.40M shares
derived: average of 4 quarters · filed 2016-11-14
2015-06-305.06M shares
10-Q · filed 2016-08-15
5.04M shares
derived: average of 2 quarters · filed 2016-08-15
5.03M shares
derived: average of 3 quarters · filed 2016-08-15
5.02M shares
derived: average of 4 quarters · filed 2016-08-15
2015-03-315.02M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-28
5.01M shares
derived: average of 2 quarters · filed 2016-06-28
5.01M shares
derived: average of 3 quarters · filed 2016-06-28
5.01M shares
10-K · filed 2016-06-28
2014-12-315.00M shares
10-Q · filed 2016-02-11
60.06M shares
10-Q · filed 2015-02-05
5.00M shares
derived: average of 2 quarters · filed 2016-02-11
5.00M shares
10-Q · filed 2016-02-11
60.03M shares
10-Q · filed 2015-02-05
-26.18M shares
derived: average of 4 quarters · filed 2016-02-11
2014-09-305.00M shares
10-Q · filed 2015-11-16
60.05M shares
10-Q · filed 2014-11-12
5.00M shares
10-Q · filed 2015-11-16
60.02M shares
10-Q · filed 2014-11-12
-36.58M shares
derived: average of 3 quarters · filed 2015-11-16
-12.69M shares
derived: average of 4 quarters · filed 2015-11-16
2014-06-305.00M shares
10-Q · filed 2015-08-06
59.99M shares
10-Q · filed 2014-07-31
-57.37M shares
derived: average of 2 quarters · filed 2015-08-06
-18.58M shares
derived: average of 3 quarters · filed 2015-08-06
-4.16M shares
derived: average of 4 quarters · filed 2015-08-06
2014-03-31-119.74M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-19
-30.37M shares
derived: average of 2 quarters · filed 2015-05-19
-7.21M shares
derived: average of 3 quarters · filed 2015-05-19
4.07M shares
10-K · filed 2015-05-19
48.85M shares
10-K · filed 2014-06-25
2013-12-3159.00M shares
10-Q · filed 2015-02-05
49.05M shares
derived: average of 2 quarters · filed 2015-02-05
45.34M shares
10-Q · filed 2015-02-05
43.48M shares
derived: average of 4 quarters · filed 2015-02-05
2013-09-3039.11M shares
10-Q · filed 2014-11-12
38.59M shares
10-Q · filed 2014-11-12
38.31M shares
derived: average of 3 quarters · filed 2014-11-12
38.17M shares
derived: average of 4 quarters · filed 2014-11-12
2013-06-3038.06M shares
10-Q · filed 2014-07-31
37.91M shares
derived: average of 2 quarters · filed 2014-07-31
37.86M shares
derived: average of 3 quarters · filed 2014-07-31
37.84M shares
derived: average of 4 quarters · filed 2014-07-31
2013-03-3137.76M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-25
37.76M shares
derived: average of 2 quarters · filed 2014-06-25
37.76M shares
derived: average of 3 quarters · filed 2014-06-25
37.76M shares
10-K · filed 2014-06-25
2012-12-3137.76M shares
10-Q · filed 2014-02-13
37.76M shares
derived: average of 2 quarters · filed 2014-02-13
37.76M shares
10-Q · filed 2014-02-13
36.32M shares
derived: average of 4 quarters · filed 2014-02-13
2012-09-3037.76M shares
10-Q · filed 2013-11-18
37.76M shares
10-Q · filed 2013-11-18
35.84M shares
derived: average of 3 quarters · filed 2013-11-18
33.94M shares
derived: average of 4 quarters · filed 2013-11-18
2012-06-3037.76M shares
10-Q · filed 2013-08-14
34.88M shares
derived: average of 2 quarters · filed 2013-08-14
32.67M shares
derived: average of 3 quarters · filed 2013-08-14
31.49M shares
derived: average of 4 quarters · filed 2013-08-14
2012-03-3131.99M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-25
30.12M shares
derived: average of 2 quarters · filed 2013-06-25
29.40M shares
derived: average of 3 quarters · filed 2013-06-25
28.97M shares
10-K · filed 2013-06-25
2011-12-3128.25M shares
10-Q · filed 2013-02-14
28.11M shares
derived: average of 2 quarters · filed 2013-02-14
27.97M shares
10-Q · filed 2013-02-14
2011-09-3027.97M shares
10-Q · filed 2012-11-09
27.83M shares
10-Q · filed 2012-11-09
2011-06-3027.69M shares
10-Q · filed 2012-08-14
2011-03-3113.30M shares
10-K · filed 2012-06-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Theravance Biopharma, Inc. (TBPH)$0.885B16.40
RIGEL PHARMACEUTICALS INC (RIGL)United States$0.893B2.25
Apnimed, Inc. (APMD)United States$0.899B
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71